References
- International Agency for Research on Cancer. Estimated age-standardized incidence rates (world) in 2018, cervix uteri, females, all ages; 2018 [cited 2020 Sept 6]. Available from: https://gco.iarc.fr/today/online-analysis-map?v=2018&mode=population&mode_population=continents&population=900&populations=900&key=asr&sex=2&cancer=23&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=1&include_nmsc_other=1&projection=natural-earth&color_palette=default&map_scale=quantile&map_nb_colors=5&continent=0&rotate=%255B10%252C0%255D.
- Vaccarella S, Franceschi S, Zaridze D, et al. Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study. Lancet Oncol. 2016;17(10):1445–1452.
- National Health Service of Latvia. Response to cervical cancer screening over 12 months in 2019 [in Latvian] [cited 2020 Sep 5]. Available from: www.vmnvd.gov.lv/lv/veselibas-aprupes-pakalpojumi/veza-savlaicigas-atklasanas-programma/programmas-rezultati.
- Centre for Disease Prevention and Control. Statistical yearbook of health care in Latvia; 2017 [cited 2018 Nov 1] (in Latvian). 19th ed. Available from: www.spkc.gov.lv/lv/statistika-un-petijumi/statistika/latvijas-veselibas-aprupes-sta1/get/nid/10.
- Marlow LAV, Chorley AJ, Haddrell J, et al. Understanding the heterogeneity of cervical cancer screening non-participants: data from a national sample of British women. Eur J Cancer. 2017;80:30–38.
- Freeman M, Waller J, Sasieni P, et al. Acceptability of non-speculum clinician sampling for cervical screening in older women: A qualitative study. J Med Screen. 2018;25(4):205–210.
- Waller J, Jackowska M, Marlow L, et al. Exploring age differences in reasons for nonattendance for cervical screening: a qualitative study. BJOG. 2012;119(1):26–32.
- Arbyn M, Anttila A, Jordan J., et al., editors. European guidelines of quality assurance of cervical cancer screening. 2nd ed. Luxembourg: Office for Official Publications of the European Communities; 2008.
- Marlow L, McBride E, Varnes L, et al. Barriers to cervical screening among older women from hard-to-reach groups: a qualitative study in England. BMC Womens Health. 2019;19(1):38.
- Chorley AJ, Marlow LA, Forster AS, et al. Experiences of cervical screening and barriers to participation in the context of an organised programme: a systematic review and thematic synthesis. Psychooncology. 2017;26(2):161–172.
- Marlow LAV, Ferrer RA, Chorley AJ, et al. Variation in health beliefs across different types of cervical screening non-participants. Prev Med. 2018;111:204–209.
- Kivistic A, Lang K, Baili P, et al. Women’s knowledge about cervical cancer risk factors, screening and reasons for non-participation in cervical cancer screening programme in Estonia. BMC Women’s Health. 2011;11:43.
- Bosgraaf RP, Ketelaars PJ, Verhoef VM, et al. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Prev Med. 2014;64:108–113.
- Enerly E, Bonde J, Schee K, et al. Self-sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian cervical cancer screening programme. PLOS One. 2016;11(4):e0151978.
- Östensson E, Alder S, Elfström KM, et al. Correction: barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23–60 years. PLOS One. 2015;10(8):e0135534.
- Favre J, Rochoy M, Raginel T, et al. The effect of cervical smears performed by general practitioners on the cervical cancer screening rate of their female patients: a claim database analysis and cross-sectional survey. J Womens Health (Larchmt). 2018;27(7):933–938.
- Virtanen A, Anttila A, Luostarinen T, et al. Improving cervical cancer screening attendance in Finland. Int J Cancer. 2015;136(6):E677–84.
- Nowakowski A, Cybulski M, Śliwczyński A, et al. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines. BMC Cancer. 2015;15:279.
- Anttila A, Nieminen P. Cervical cancer screening programme in Finland. Eur J Cancer. 2000;36(17):2209–2214.
- Musa J, Achenbach CJ, O'Dwyer LC, et al. Effect of cervical cancer education and provider recommendation for screening on screening rates: a systematic review and meta-analysis. PLOS One. 2017;12(9):e0183924.
- Baron RC, Melillo S, Rimer BK, Task Force on Community Preventive Services, et al. Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders. Am J Prev Med. 2010;38(1):110–117.
- Anttila A, Arbyn A, De Vuyst H, et al., editors. Organization of cytology-based or HPV-based cervical cancer screening. European guidelines for quality assurance in cervical cancer screening. 2nd ed (suppl). Luxembourg: Publications Office of the European Union; 2015.
- Bennett KF, Waller J, Chorley AJ, et al. Barriers to cervical screening and interest in self-sampling among women who actively decline screening. J Med Screen. 2018;25(4):211–217.